Cargando…
Drug repurposing for COVID-19: Approaches, challenges and promising candidates
Traditional drug development and discovery has not kept pace with threats from emerging and re-emerging diseases such as Ebola virus, MERS-CoV and more recently, SARS-CoV-2. Among other reasons, the exorbitant costs, high attrition rate and extensive periods of time from research to market approval...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220862/ https://www.ncbi.nlm.nih.gov/pubmed/34174275 http://dx.doi.org/10.1016/j.pharmthera.2021.107930 |